Sources | Names Used |
---|---|
CTRPv2 | alisertib:navitoclax (2:1 mol/mol) |
PharmacoGx | alisertib:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF783 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
mRNA | ZNF776 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | ZNF775 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-08 |
mRNA | ZNF77 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | ZNF766 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-10 |
mRNA | ZNF765 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | ZNF737 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | ZNF736 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | ZNF730 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | ZNF724 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |